Abstract:Rationale: Dysregulation of the PI3K/AKT/mTOR pathway occurs frequently in cancers, providing an attractive therapeutic target for anticancer treatments. DEPTOR plays essential roles in regulation of cell proliferation and survival by directly modulating mTOR activity. However, whether DEPTOR regulates the growth of ErbB2-positive breast cancer cells remains unknown. Methods: DEPTOR expression was determined by TCGA data analysis and immunohistochemistry of human breast tissue microarrays. The membrane localization of DEPTOR was demonstrated by immunofluorescence and subcellular fractionation. The interaction of DEPTOR with ErbB2 was determined by immunoprecipitation. Furthermore, the biological significance of this interaction was assessed by ATPlite cell growth, clonogenic survival, and flow cytometry-based apoptosis assays. Results: DEPTOR promoted the proliferation and survival of ErbB2-positive breast cancer cells by directly interacting with and stabilizing ErbB2. Specifically, DEPTOR translocates to cell membrane and interacts with ErbB2 to disrupt ErbB2 polyubiquitination and degradation promoted by β-TrCP, an E3 ubiquitin ligase. DEPTOR knockdown destabilizes ErbB2 by shortening its protein half-life to inactivate ErbB2-PI3K-AKT-mTOR signaling, leading to the suppression of cell proliferation and survival by inducing apoptosis. Ectopic expression of a constitutively active ErbB2 mutant completely rescued the reduction in cell proliferation and survival by DEPTOR knockdown. Importantly, DEPTOR expression is increased in human breast cancer tissues and its overexpression correlates with poor patient survival. Moreover, DEPTOR is located on the cell membrane in ErbB2-positive breast cancer tissues, but not in tumor-adjacent normal tissues, indicating that DEPTOR may contribute to the oncogenic characteristics of ErbB2. Conclusions: Our study reveals a novel mechanism by which DEPTOR promotes breast cancer cell proliferation and survival by stabilizing ErbB2.

Inhibiting HSD17B8 suppresses the cell proliferation caused by PTEN failure

DEPTOR is a Direct P53 Target That Suppresses Cell Growth and Chemosensitivity

DEPTOR Stabilizes ErbB2 to Promote the Proliferation and Survival of ErbB2-positive Breast Cancer Cells.

DAF-18/PTEN inhibits germline zygotic gene activation during primordial germ cell quiescence

Pten Modulates Cell Cycle Progression and Cell Survival by Regulating Phosphatidylinositol 3,4,5,-Trisphosphate and Akt Protein Kinase B Signaling Pathway

Regulation of the tumor suppressor PTEN by natural anticancer compounds

PTENless means more.

PTEN Inhibits the Migration and Invasion of HepG2 Cells by Coordinately Decreasing MMP Expression Via the PI3K/Akt Pathway

LncRNAs-directed PTEN Enzymatic Switch Governs Epithelial–mesenchymal Transition

Pten Deficiency Activates Distinct Downstream Signaling Pathways in A Tissue-Specific Manner

PTEN inhibits proliferation of cervical cancer cells by AKT mediated cell metabolism

PTEN Regulates Angiogenesis and VEGF Expression Through Phosphatase-Dependent and -Independent Mechanisms in HepG2 Cells

Data from Adaptive Basal Phosphorylation of Eif2α is Responsible for Resistance to Cellular Stress–Induced Cell Death in Pten-Null Hepatocytes

GSK3 β mediates suppression of cyclin D2 expression by tumor suppressor PTEN

MDH2 Stimulated by Estrogen-GPR30 Pathway Down-Regulated PTEN Expression Promoting the Proliferation and Invasion of Cells in Endometrial Cancer.

PTENε Suppresses Tumor Metastasis Through Regulation of Filopodia Formation.

C-Terminal Pten Is Essential For Maintenance Of Genomic Stability And Tumor Suppression

Ptenp1, A Natural Sponge of Mir-21, Mediates Pten Expression to Inhibit the Proliferation of Oral Squamous Cell Carcinoma

Data from Murine Cell Lines Derived from <i>Pten</i> Null Prostate Cancer Show the Critical Role of PTEN in Hormone Refractory Prostate Cancer Development

PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis

Investigate the Role of PTEN in Chemotaxis of Human Breast Cancer Cells.